Chiral Technologies, a unit of Japan’s Daicel specialized in enantioselective chromatography, has appointed Joseph M. Barendt as its new president.
Prior to the appointment, Barendt, who earned a Ph.D in chemistry from the University of Colorado and an MBA from the Joseph M. Katz School of Business at the University of Pittsburgh – both in the US – served as the company’s chief operating officer.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
Compelling solutions through strategic partnerships
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.
